Focus Financial Network
IHE icon

Focus Financial Network’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Focus Financial Network’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2,221
Closed -$220K – 783
2026
Q2 		$220K Buy
+2,221
New +$200K 0.01% 718

Other funds holding IHE

MinichMacGregor Wealth Management
MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return
Well Done LLC
Well Done LLC Holland, Michigan $732M AUM 14.62% 1-Year Est. Return
Advisornet Financial
Advisornet Financial Minnetonka, Minnesota $2.21B AUM 14.38% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $338M AUM 49.03% 1-Year Est. Return
Cadent Capital Advisors
Cadent Capital Advisors Tulsa, Oklahoma $466M AUM 30.56% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
WWMP
Wagner Wealth Management (Pennsylvania) Conyngham, Pennsylvania $128M AUM 17.98% 1-Year Est. Return
Massachusetts Wealth Management
Massachusetts Wealth Management North Andover, Massachusetts $248M AUM 37.44% 1-Year Est. Return
Strategy Asset Managers
Strategy Asset Managers Pasadena, California $650M AUM 25.51% 1-Year Est. Return
Schuylkill Financial
Schuylkill Financial Wyomissing, Pennsylvania $102M AUM

Focus Financial Network's IHE Position: Q3 2026 in Review

Focus Financial Network sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2026, closing a stake of 2,221 shares — an estimated $220K sold.

Focus Financial Network first reported a position in IHE in Q2 2026 and held it in 1 quarter. The position peaked at $220K in Q2 2026. 50 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • Focus Financial Network reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2026 after selling out during the quarter.
  • Focus Financial Network sold 2,221 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $220K.
  • Focus Financial Network first reported a position in iShares US Pharmaceuticals ETF in Q2 2026 and held it in 1 quarter.
  • Focus Financial Network's iShares US Pharmaceuticals ETF position peaked at $220K in Q2 2026.
  • 50 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Focus Financial Network's 13F filing for Q3 2026, filed 14 Oct 2026.